Clinical

The Diagnosis and Management of Bipolar Disorder in Children and Adolescents

By: Marie Huang - The amphitheater at Nassau University Medical Center fills up slowly as Dr. Alan Jay Cohen, a…

14 years ago

Jentadueto Approved by FDA for Type 2 Diabetes Mellitus

By: Ebey P. Soman - The FDA recently approved a combination tablet of linagliptin with metformin hydrochloride (Jentadueto®) for the…

14 years ago

FDA Makes Label Changes to Statins

By: Mohamed Dungersi - On February 28, the U.S. Food and Drug Administration (FDA) approved important safety label changes for…

14 years ago

CHF, a Rare but Serious Presentation of Graves’ disease

By: James Schurr, Pharm.D. Candidate c/o 2014 - Graves’ disease is an autoimmune disorder that results in a state of…

14 years ago

Link Revealed: PPI Usage, Smoking and Bone Fractures

By: Ebey P. Soman - Proton pump inhibitors (PPIs) are medications commonly prescribed to treat heartburn, acid reflux disease, and…

14 years ago

Brilinta® vs. Plavix® in Patients with Acute Coronary Syndromes

By: Ronik Saha, Pharm.D. Candidate c/o 2013 - Clopidogrel (Plavix®) is a thienopyridine antiplatelet agent, which exerts its antiplatelet effects…

14 years ago

Proton Pump Inhibitors and the Treatment of Osteoporosis

By: Neal Shah - Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces…

14 years ago

Bydureon®: A Weekly Injection for Type 2 Diabetes Mellitus

By: Mohamed Dungersi - On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus…

14 years ago

Hope on the Horizon: Chikungunya Vaccine Trial Begins!

By: Ebey P. Soman - Since its discovery in Tanganyika (modern day Mozambique and Tanzania in Africa) in 1952, Chikungunya…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago